Omnio
Biotech startup developing a plasminogen-based therapy for hard-to-heal chronic wounds.
Omnio is a biotech & life sciences company based in Umeå, SE. It has raised $3.26 million in disclosed funding. Its latest round was a Seed of €2.9 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $3.3M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Omnio do?
Biotech startup developing a plasminogen-based therapy for hard-to-heal chronic wounds.
How much has Omnio raised?
Omnio has raised $3.26 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Omnio?
Investors in Omnio include existing investors and shareholders.
When and where was Omnio founded?
Omnio and is based in Umeå, SE.
Sources
- 1.Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds — EU-Startups, Oct 2, 2026